Tags : Years

Tolmar’s Fensolvi Received the US FDA’s Approval to Treat Pediatric

Shots: The approval is based on P-III study which involves assessing of leuprolide acetate (LA,45 mg) in 64 children with central (gonadotropin-dependent) precocious puberty evaluating its safety and pharmacokinetics The study achieved its 1E i.e. 87% of children achieved a serum luteinizing hormone concentration of <4 IU/L at six months post injection with most common […]Read More

GSK Signs a Five Years Collaboration with Lyell to Develop

Shots: Lyell to apply its technologies to strengthen GSK’s cell therapy pipeline including GSK3377794 targeting the NY-ESO-1 antigen expressed along multiple cancer plus an approach to counter T cell exhaustion while increasing probability for delivering cancer therapies The focus of the agreement is to combine the GSK’s strong cell and gene therapy programmes with Lyell’s […]Read More